Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003769 · ClinicalTrials.gov registry record · Phase 2
Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer
A Phase 2 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003769 is a Phase 2 study that has completed, run by Indiana University.
The verdict
NCT00003769, a Phase 2 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol followed by surgery in treating patients who have stage II or stage III pancreatic cancer.
Interventions
- DRUG perillyl alcohol
- PROCEDURE surgical procedure
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-02 |
| Est. Completion | 2001-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003769
The ClinicalTrials.gov registry entry for NCT00003769 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which perillyl alcohol is the first listed.
NCT00003769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003769 about?
NCT00003769 is a clinical study titled "Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol followed b...
What is the current status of trial NCT00003769?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-02. Estimated completion is 2001-07.
What interventions are being tested in trial NCT00003769?
The interventions under investigation include: perillyl alcohol (DRUG), surgical procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00003769?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.